Track A: Biologics Stability Workshop with Prometheus™ Panta
Explore protein thermal and colloidal stability characterization. Learn how Prometheus Panta simultaneously measures nanoDSF™, DLS, SLS, and backreflection to support formulation development, candidate selection, and stability screening with minimal sample consumption and maximum data confidence.
Track B: Binding Affinity Workshop with Monolith & Dianthus
Dive into solution-based binding affinity measurements. Discover how Monolith Spectral shift & TRIC technology enables Kd determination with minimal sample consumption, and how Dianthus with Spectral Shift & TRIC unlocks hit validation and lead optimization for challenging binding interactions that are difficult to characterize with conventional methods.
Welcome & NanoTemper portfolio presentation (30 min)
Keynote address: Dr. J. Fraser Glickman, PhD — Director, Fisher Drug Discovery Resource Center, the Rockefeller University (30 min)
Guided tour of the Fisher Drug Discovery Resource Center (30 min)
Networking & coffee break
Lunch — Provided for all attendees
Parallel afternoon workshop tracks begin. Full details above.
Day 1 Close. Event may end earlier or later.
Registration & welcome coffee — Day 2 check-in
Own-sample evaluation sessions — Guided by NanoTemper Field Application Scientists. Attendees who wish to have their own samples assessed on our technology will work directly alongside NanoTemper’s Field Application Scientists in a guided, personalized setting. This is a unique opportunity to see how our biophysical platforms perform with your specific molecules and research questions.
Lunch Break
Own-sample evaluation sessions resume — Continued hands-on instrument time
One-on-one scientific consultations with the NanoTemper team
Workshop wrap-up, Q&A, and closing remarks
The Fisher Drug Discovery Resource Center (DDRC) at The Rockefeller University is one of the foremost academic facilities for early-stage drug discovery in the United States. Established in 2003 and operating on an open-access model, the DDRC provides Rockefeller researchers and collaborators with access to a diverse collection of over 635,000 drug-like compounds, cutting-edge laboratory automation, and state-of-the-art bioassay technologies.
The Center has been directed since 2008 by Dr. J. Fraser Glickman, PhD, a Research Associate Professor and accomplished scientist with over three decades of experience in the pharmaceutical industry. Under Dr. Glickman’s leadership, the DDRC bridges the gap between basic academic research and therapeutic development — working closely with investigators to design and validate novel assays, deploy high-throughput screening strategies, and identify lead compounds with real therapeutic potential. The Center’s mission is rooted in the principle that rigorous, technology-driven science is essential to accelerating the discovery of new medicines, making it an ideal partner for this collaborative workshop with NanoTemper Technologies.
June 2–3, 2026
The Fisher Drug Discovery Resource Center
The Rockefeller University
1230 York Avenue, New York, NY 10065